
|
DEVICE CONGRESS - AT-A-GLANCE
|
MARCH 28, 2007
|
PRECONFERENCE SESSIONS
8:30 am - 11:45 am
|
PRECON I
Implementing International Codes of Conduct |
PRECON II
Understanding Private Payers and Maximizing Private Payer Reimbursement Strategies |
PRECON III
After the Inspection: Managing FDA Enforcement Actions
|
|
GENERAL SESSION
1:00 pm - 5:30 pm
|
|
1:00 pm |
Welcome |
John Bentivoglio, Esq. and Nancy Singer, Esq.
|
|
1:10 pm |
What We Know and What We Came to Learn |
Arthur Miller, Esq.
|
|
1:35 pm |
Advocating for Reasonable Regulation |
Stephen Ubl, AdvaMed
|
|
2:15 pm |
CDRH's Regulatory Agenda for 2007 - 2008 |
Tim Ulatowski, CDRH
|
|
3:15 pm |
International Harmonization: Reality or Fantasy |
Larry Kessler, ScD, CDRH and Michael Gropp, Medtronic, Inc.
|
|
4:10 pm |
CMS Priorities for 2007 - 2008: What Device Innovators Should Know about Medicare Reimbursement |
Carol Kelly, CMS
|
|
4:50 pm |
Fraud and Abuse: Lessons Learned from Government Prosecutions |
Michael Loucks, US Attorney's Office
|
|
5:30 pm |
Adjournment |
|
|
5:45 pm |
Reception - Harvard Faculty Club |
|
|
7:00 pm |
PricewaterhouseCoopers Banquet |
|
|
|
MARCH 29, 2007
|
MORNING TRACKS
8:30 am - 12:00 pm
|
|
QUALITY TRACK |
REIMBURSEMENT TRACK |
FRAUD AND ABUSE TRACK |
INTERNATIONAL TRACK
|
|
8:30 am |
Welcome |
Welcome |
Welcome |
Welcome
|
|
8:40 am |
Using Management Controls to Translate Policies and Principles into Practice |
The Alphabet Soup of Clinical Quality Standards: What's Important? What Isn't |
Results from the PWC, King & Spalding and Compliance-Alliance Survey |
Current Regulatory Challenges in Asia
|
|
9:20 am |
Implementing Effective Supplier Management Programs |
Quality, Performance Measures and practice Guidelines: What Technology Manufacturers Should Know |
The OIG - Getting Companies to Comply with the Law |
Regulatory Initiatives in Europe
|
|
10:30 am |
Creating an Effective Internal Audit Program |
A Dash of FDA, a Pinch of CMS and What Do You Get? |
AdvaMed's Efforts to Promote Regulatory Compliance |
Opportunities in South America
|
|
11:10 am |
Building a Cradle-to-Grave Approach with Your Design Documentation and Data |
Making the Case for the Value of Your Device with Practice-Based Evidence |
What Healthcare Providers Are Doing to Promote Regulatory Compliance |
Doing Business in Ireland
|
|
11:35 am |
|
|
What GPO's Are Doing to Promote Regulatory Compliance |
|
|
AFTERNOON TRACKS
1:30 pm - 6:00 pm
|
|
QUALITY TRACK |
REIMBURSEMENT TRACK |
FAIR MARKET VALUE (FMV) AND PROMOTION |
|
|
1:30 pm |
Welcome |
Welcome |
Welcome |
|
|
1:40 pm |
Assessing Complaints and Service Reports |
How to Convince the Medical Director Your Product Is Special |
Fair Market Value (FMV) Assessments for Health Care Professionals |
|
|
2:20 pm |
Implementing an Effective CAPA System |
Coding Trends: How to Get Your Device Through the Coding Maze |
|
|
|
3:30 pm |
Setting Up a Defensible System to Make Reports of Removals and Corrections |
Countering the Cuts - Acute Care: Managing Hospital and ASC Payment Policy for Your Products |
The Regulatory Authority for Off-Label Promotion and Recent Enforcement Actions |
|
|
3:55 pm |
|
Countering the Cuts - Acute Care: Managing Payment Policy and Your Post Acute Care Products Across Systems and Through Competitive Bidding |
Action Items: Monitoring Off-Label Promotion Do's and Don'ts |
|
|
4:10 pm |
Lessons Learned in Integrating Risk management and Process Validation |
|
Action Items: Monitoring Off-Label Promotion Do's and Don'ts |
|
|
4:35 pm |
|
Coping with Reimbursement Rules and Challenges: Survey Results on How Device Companies Deploy Their Resources |
|
|
|
4:50 pm |
Putting Together a Global Regulatory/Quality System |
|
|
|
|
5:15 pm |
|
Developing a Strategic Reimbursement Plan |
|
|
|
5:30 pm |
Adjournment |
Adjournment |
Adjournment |
Adjournment
|
|
|
MARCH 30, 2007
|
GENERAL SESSION
8:30 am - 11:30 am
|
|
8:30 pm |
Lessons Learned from the Mistakes of Others |
Susan Alpert, PhD, MD, Medtronic, Inc.
John Bentivoglio, Esq. King and Spalding
Martin Browning, EduQuest
Bob Klepinski, Esq. Fredrickson & Byron
Robert O'Holla, Johnson & Johnson
Randel Richner, Neocure
Jim Sheehan, Esq. U.S. Attorney's Office
Nancy Singer, Esq. Compliance-Alliance
John Taylor III, Abbott Laboratories
|
|
11:30 am |
What We Learned and What Information Will We Be Able to Put to Use |
Arthur Miller, Esq.
|
|
12:00 pm |
Adjournment |
|
|
|
|

|